Search Results - "Kalaycio, M"

Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms by Traina, F, Visconte, V, Elson, P, Tabarroki, A, Jankowska, A M, Hasrouni, E, Sugimoto, Y, Szpurka, H, Makishima, H, O'Keefe, C L, Sekeres, M A, Advani, A S, Kalaycio, M, Copelan, E A, Saunthararajah, Y, Olalla Saad, S T, Maciejewski, J P, Tiu, R V

“…We hypothesized that specific molecular mutations are important biomarkers for response to DNA methyltransferase inhibitors (DNMT inhibitors) and may have…”
Get full text

Incorporation of molecular data into the Revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes by Nazha, A, Narkhede, M, Radivoyevitch, T, Seastone, D J, Patel, B J, Gerds, A T, Mukherjee, S, Kalaycio, M, Advani, A, Przychodzen, B, Carraway, H E, Maciejewski, J P, Sekeres, M A

“…The Revised International Prognostic Scoring System (IPSS-R) was developed for untreated myelodysplastic syndrome (MDS) patients based on clinical data. We…”
Get full text

Hematopoietic cell transplantation for primary plasma cell leukemia: results from the Center for International Blood and Marrow Transplant Research by Mahindra, A, Kalaycio, M E, Vela-Ojeda, J, Vesole, D H, Zhang, M-J, Li, P, Berenson, J R, Bird, J M, Dispenzieri, A, Gajewski, J L, Gale, R P, Holmberg, L, Kumar, S, Kyle, R A, Lazarus, H M, Lonial, S, Mikhael, J, Milone, G A, Munker, R, Nath, R, Saccaro, S, To, L Bik, Vogl, D T, Wirk, B, Hari, P

“…There are limited data on hematopoietic cell transplantation (HCT) in primary plasma cell leukemia (pPCL), an aggressive plasma cell disorder. We report…”
Get full text

Defining AML and MDS second cancer risk dynamics after diagnoses of first cancers treated or not with radiation by Radivoyevitch, T, Sachs, R K, Gale, R P, Molenaar, R J, Brenner, D J, Hill, B T, Kalaycio, M E, Carraway, H E, Mukherjee, S, Sekeres, M A, Maciejewski, J P

“…Risks of acute myeloid leukemia (AML) and/or myelodysplastic syndromes (MDS) are known to increase after cancer treatments. Their rise-and-fall dynamics and…”
Get full text

Risk of developing chronic myeloid neoplasms in well-differentiated thyroid cancer patients treated with radioactive iodine by Molenaar, R J, Pleyer, C, Radivoyevitch, T, Sidana, S, Godley, A, Advani, A S, Gerds, A T, Carraway, H E, Kalaycio, M, Nazha, A, Adelstein, D J, Nasr, C, Angelini, D, Maciejewski, J P, Majhail, N, Sekeres, M A, Mukherjee, S

“…Exposure to ionizing radiation increases the risk of myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPN), but such risks are not known in…”
Get full text

Potentiation of apoptosis by histone deacetylase inhibitors and doxorubicin combination: cytoplasmic cathepsin B as a mediator of apoptosis in multiple myeloma by Cheriyath, V, Kuhns, M A, Kalaycio, M E, Borden, E C

“…Background: Although inhibitors of histone deacetylase inhibitors (HDACis) in combination with genotoxins potentiate apoptosis, the role of proteases other…”
Get full text

The relationship between eligibility criteria and adverse events in randomized controlled trials of hematologic malignancies by Statler, A, Radivoyevitch, T, Siebenaller, C, Gerds, A T, Kalaycio, M, Kodish, E, Mukherjee, S, Cheng, C, Sekeres, M A

“…To minimize adverse events (AEs) unrelated to drugs and maximize the likelihood of drug approvals, eligibility criteria for randomized controlled trials (RCTs)…”
Get full text

Risk factors for vancomycin-resistant enterococcus bacteremia and its influence on survival after allogeneic hematopoietic cell transplantation by Tavadze, M, Rybicki, L, Mossad, S, Avery, R, Yurch, M, Pohlman, B, Duong, H, Dean, R, Hill, B, Andresen, S, Hanna, R, Majhail, N, Copelan, E, Bolwell, B, Kalaycio, M, Sobecks, R

“…Vancomycin-resistant enterococcus (VRE) is a well-known infectious complication among immunocompromised patients. We performed a retrospective analysis to…”
Get full text

Ruxolitinib leads to improvement of pulmonary hypertension in patients with myelofibrosis by Tabarroki, A, Lindner, D J, Visconte, V, Zhang, L, Rogers, H J, Parker, Y, Duong, H K, Lichtin, A, Kalaycio, M E, Sekeres, M A, Mountantonakis, S E, Heresi, G A, Tiu, R V

“…Pulmonary hypertension (PH) is a frequently under recognized complication of myelofibrosis (MF). The pathophysiology of PH in MF is unknown and no definitive…”
Get full text

A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation by BOLWELL, B, SOBECKS, R, POHLMAN, B, ANDRESEN, S, RYBICKI, L, KUCZKOWSKI, E, KALAYCIO, M

“…Cyclosporine (CSP) and short course methotrexate (MTX) have been the gold standard for GVHD prophylaxis for decades. Problems associated with MTX include…”
Get full text

Quality of life and outcomes in patients⩾60 years of age after allogeneic hematopoietic cell transplantation by Hamilton, B K, Rybicki, L, Dabney, J, McLellan, L, Haddad, H, Foster, L, Abounader, D, Kalaycio, M, Sobecks, R, Dean, R, Duong, H, Hill, B T, Bolwell, B J, Copelan, E A

“…Hematopoietic cell transplantation (HCT) has become an established standard of care for many older patients with hematologic malignancies. The effect of…”
Get full text

Prognostic significance of pre-transplant quality of life in allogeneic hematopoietic cell transplantation recipients by Hamilton, B K, Law, A D, Rybicki, L, Abounader, D, Dabney, J, Dean, R, Duong, H K, Gerds, A T, Hanna, R, Hill, B T, Jagadeesh, D, Kalaycio, M E, Lawrence, C, McLellan, L, Pohlman, B, Sobecks, R M, Bolwell, B J, Majhail, N S

“…Quality of life (QOL) is an important outcome for hematopoietic cell transplantation (HCT) recipients. Whether pre-HCT QOL adds prognostic information to…”
Get full text

BECN1 and BIM interactions with MCL-1 determine fludarabine resistance in leukemic B cells by Sharma, A, Singh, K, Mazumder, S, Hill, B T, Kalaycio, M, Almasan, A

“…The purine analog fludarabine (Fd) is an essential therapeutic for chronic lymphocytic leukemia (CLL). Innate or acquired resistance to Fd is a significant…”
Get full text

Efficacy of rabbit anti-thymocyte globulin in severe aplastic anemia by AFABLE, Manuel G, SHAIK, Mohammed, TIU, Ramon V, O'KEEFE, Christine L, MACIEJEWSKI, Jaroslaw P, SUGIMOTO, Yuka, ELSON, Paul, CLEMENTE, Michael, MAKISHIMA, Hideki, SEKERES, Mikkael A, LICHTIN, Alan, ADVANI, Anjali, KALAYCIO, Matt

“…A combination of horse anti-thymocyte globulin and cyclosporine produces responses in 60-70% of patients with severe aplastic anemia. We performed a phase II…”
Get full text

Impact of cigarette smoking on survival after myeloablative allogeneic hematopoietic stem cell transplantation and contribution of invasive fungal infection by Mehdi, A, Rybicki, L, Mossad, S, Yurch, M, Sekeres, M, Gerds, A T, Jagadeesh, D, Hamilton, B, Liu, H, Dean, R, Pohlman, B, Sobecks, R, Andresen, S, Kalaycio, M, Bolwell, B J, Majhail, N S, Copelan, E, Hill, B T

Get full text

Association of socioeconomic status with long-term outcomes in 1-year survivors of allogeneic hematopoietic cell transplantation by Fu, S, Rybicki, L, Abounader, D, Andresen, S, Bolwell, B J, Dean, R, Gerds, A, Hamilton, B K, Hanna, R, Hill, B T, Jagadeesh, D, Kalaycio, M E, Liu, H D, Pohlman, B, Sobecks, R M, Majhail, N S

“…The relationship of socioeconomic status (SES) with long-term outcomes in allogeneic hematopoietic cell transplantation (HCT) survivors has not been well…”
Get full text

Racial differences in allogeneic hematopoietic cell transplantation outcomes among African Americans and whites by Hamilton, B K, Rybicki, L, Sekeres, M, Kalaycio, M, Hanna, R, Sobecks, R, Dean, R, Duong, H, Hill, B T, Bolwell, B, Copelan, E

“…The impact of race on outcome has been identified in a number of cancers, with African Americans having poorer survival compared with whites. We conducted a…”
Get full text

p53 Independent epigenetic-differentiation treatment in xenotransplant models of acute myeloid leukemia by Ng, K P, Ebrahem, Q, Negrotto, S, Mahfouz, R Z, Link, K A, Hu, Z, Gu, X, Advani, A, Kalaycio, M, Sobecks, R, Sekeres, M, Copelan, E, Radivoyevitch, T, Maciejewski, J, Mulloy, J C, Saunthararajah, Y

“…Suppression of apoptosis by TP53 mutation contributes to resistance of acute myeloid leukemia (AML) to conventional cytotoxic treatment. Using differentiation…”
Get full text

Association of socioeconomic status with autologous hematopoietic cell transplantation outcomes for lymphoma by Hong, S, Rybicki, L, Abounader, D M, Bolwell, B J, Dean, R, Gerds, A T, Hamilton, B K, Hill, B T, Jagadeesh, D, Kalaycio, M, Liu, H D, Pohlman, B, Sobecks, R, Majhail, N S

“…Socioeconomic status (SES) is an important determinant of disparities in health care. The association of SES with outcomes in autologous hematopoietic cell…”
Get full text

United States Multicenter Study of Arsenic Trioxide in Relapsed Acute Promyelocytic Leukemia by SOIGNET, Steven L, FRANKEL, Stanley R, SIEVERS, Eric L, COUTRE, Steven, DAHLBERG, Steve, ELLISON, Ralph, WARRELL, Raymond P, DOUER, Dan, TALLMAN, Martin S, KANTARJIAN, Hagop, CALLEJA, Elizabeth, STONE, Richard M, KALAYCIO, Matt, SCHEINBERG, David A, STEINHERZ, Peter

“…To determine the safety and efficacy of arsenic trioxide (ATO) in patients with relapsed acute promyelocytic leukemia (APL). Forty patients experiencing first…”
Get full text